Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
In millions, except per share items | Jan-01-21 | Oct-02-20 | Jul-03-20 | Mar-31-20 | Dec-31-19 | Sep-30-19 | Jun-30-19 | Mar-31-19 |
| 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K |
Revenues: |
Defense and Intelligence | 3,126 | 3,144 | 3,125 | 3,101 | 3,081 | 2,977 | 2,902 | 2,587 |
Civilian and Health Care | 1,357 | 1,331 | 1,380 | 1,403 | 1,418 | 1,471 | 1,442 | 1,443 |
Total revenues | 4,483 | 4,475 | 4,505 | 4,504 | 4,499 | 4,448 | 4,344 | 4,030 |
Revenue growth [+] | -0.4% | 0.6% | 3.7% | 11.8% | -21.8% | -5.0% | 20.3% | 43.0% |
Defense and Intelligence | 1.5% | 5.6% | 7.7% | 19.9% | | | | |
Civilian and Health Care | -4.3% | -9.5% | -4.3% | -2.8% | | | | |
Cost of goods sold | 8,072 | 8,048 | 8,059 | 8,005 | 6,689 | 5,772 | 4,808 | 4,515 |
Gross profit | -3,589 | -3,573 | -3,554 | -3,501 | -2,190 | -1,324 | -464 | -485 |
Gross margin | -80.1% | -79.8% | -78.9% | -77.7% | -48.7% | -29.8% | -10.7% | -12.0% |
Selling, general and administrative | 3,435 | 3,455 | 3,471 | 3,481 | 3,041 | 3,991 | 4,942 | 5,622 |
Other operating expenses | -6,644 | -6,689 | -6,699 | -6,694 | -5,819 | -5,728 | -5,682 | -6,219 |
EBITDA [+] | -289 | -248 | -235 | -197 | 704 | 605 | 542 | 442 |
EBITDA growth | -141.1% | -141.0% | -143.4% | -144.6% | 75.1% | 86.7% | 119.4% | 81.1% |
EBITDA margin | -6.4% | -5.5% | -5.2% | -4.4% | 15.6% | 13.6% | 12.5% | 11.0% |
Depreciation | 195 | 223 | 217 | 222 | 247 | 383 | 367 | 330 |
EBITA | -484 | -471 | -452 | -419 | 457 | 222 | 175 | 112 |
EBITA margin | -10.8% | -10.5% | -10.0% | -9.3% | 10.2% | 5.0% | 4.0% | 2.8% |
Amortization of intangibles | 181 | | | | 152 | | | |
EBIT [+] | -665 | -623 | -604 | -571 | 305 | 222 | 175 | 112 |
EBIT growth | -318.0% | -380.6% | -445.1% | -609.8% | 122.6% | 149.4% | 230.2% | 45.5% |
EBIT margin | -14.8% | -13.9% | -13.4% | -12.7% | 6.8% | 5.0% | 4.0% | 2.8% |
Non-recurring items | 33 | 31 | 20 | | | 4 | 2 | |
Interest expense | 87 | 93 | 100 | | 105 | 71 | 35 | |
Interest expense | 87 | 93 | 100 | 105 | 105 | 71 | 35 | 121 |
Other income (expense), net | | | | -9 | | | | 121 |
Pre-tax income | -794 | -756 | -733 | -689 | 182 | 133 | 124 | 112 |
Income taxes | -72 | -64 | -59 | -54 | 47 | 35 | 39 | 40 |
Tax rate | 9.1% | 8.5% | 8.0% | 7.8% | 25.8% | 26.3% | 31.5% | |
Net income | -722 | -692 | -674 | -635 | 135 | 98 | 85 | 72 |
Net margin | -16.1% | -15.5% | -15.0% | -14.1% | 3.0% | 2.2% | 2.0% | 1.8% |
|
Basic EPS [+] | ($5.97) | ($5.71) | ($5.55) | ($3.92) | $0.83 | $0.60 | $0.52 | $0.44 |
Growth | -819.8% | -1052.8% | -1172.1% | -997.4% | 7.5% | -51.1% | -62.6% | -70.1% |
Diluted EPS [+] | ($5.94) | ($5.69) | ($5.53) | ($3.90) | $0.83 | $0.60 | $0.52 | $0.44 |
Growth | -818.8% | -1051.4% | -1170.9% | -996.1% | 7.3% | -51.2% | -62.6% | -70.2% |
|
Dividends per share [+] | $0.26 | $0.26 | $0.25 | | $0.17 | $0.11 | $0.05 | |
Growth | 53.8% | 132.4% | 407.0% | | | | | |
|
Shares outstanding (basic) [+] | 121 | 121 | 122 | 162 | 163 | 163 | 164 | 165 |
Growth | -25.7% | -25.9% | -26.0% | -1.7% | 2.1% | 6.1% | 10.8% | 15.9% |
Shares outstanding (diluted) [+] | 122 | 122 | 122 | 163 | 163 | 164 | 165 | 165 |
Growth | -25.6% | -25.8% | -26.0% | -1.6% | 2.3% | 6.3% | 11.0% | 16.0% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|